Send to printer »

People in the News : Oct 15, 2012 (Vol. 32, No. 18)

People in the News

Chembio Diagnostics hired Sharon Klugewicz as vp of quality assurance/quality control and technical operations. Previously, she was svp, scientific and laboratory services at Pall and also held positions in the Pall Life Sciences division in marketing, product management, and global quality operations.

 

DART Therapeutics appointed Eugene W. Williams as CEO, Ernest D. Bush, Ph.D., as CSO, Elliot Goldstein, M.D., as CMO, and Cabot Brown as CFO...AMRI promoted Daniel Conlon to senior director of business development and elected Michael Nolan as vp, CFO, and treasurer.

 

Genomind appointed Rudolph E. Tanzi, Ph.D., to its scientific advisory board. Dr. Tanzi is director of the genetics and aging research unit at the MassGeneral Institute for Neurodegenerative Disease. In addition, he is a professor of neurology at Harvard University.

 

Brett Haumann, M.D., is now CMO at Circassia...ChanTest hired Chris Mathes as CCO...Will Lewis is now president and CEO at Insmed...Visterra added Donna M. Ambrosino, M.D., as CMO...Aptiv Solutions appointed Scott Gottlieb, M.D., to its board of directors.

 

Ken Keller is now evp and COO at Spectrum Pharmaceuticals. Before joining Spectrum, Keller spent 21 years at Amgen. Most recently he was vp and general manager, Bone Health Business Unit. Prior to this, he was responsible for the Inflammation Business Unit.

 

InVivo Therapeutics appointed Arthur J. Coury, Ph.D., to its business advisory board...Osmotica Pharmaceutical hired Darren Alkins as evp...Retrophin named Stephen Aselage as CEO...Thomas Pitler, Ph.D., is now vp of business development at A.P. Pharma.

 

Mucosis promoted Thomas Johnston to CEO. Johnston joined Mucosis in May 2011 as CBO. Previously, he was vp of strategy at Novavax. Prior to Novavax, he held various senior-level positions with Comcast, Microsoft, and Schlumberger.

 

Tobira Therapeutics added Caroline Loewy as evp and CFO, Jeff Enejosa, M.D., as senior director of clinical research, and Mark Menning as director of pharmaceutical sciences...Patrick Gallagher joined Kinex Pharmaceuticals as vp of business development and investor relations...CMC Biologics hired Mark W. Sawicki as vp of global business development.

 

Victor Vinci, Ph.D., joined Cook Pharmica as CSO. Prior to Cook Pharmica, Dr. Vinci worked at Eli Lilly in leading bioprocess operations and development efforts. He was also at Merck as a manufacturing science and technology lead and section head.

 

Nuovo Biologics appointed Robert G. Savage to its board...Amgen named Ray Jordan as svp, corporate affairs...Christopher Allen Michaels has joined Rapid Pathogen Screening as vp of strategic development and technology licensing...Teva Pharmaceutical hired Jonathan L. Isaacsohn, M.D., as CMO...Merz added Cynthia Schwalm as vp, neurology...Transgenomic appointed Mark P. Colonnese as CFO.

 

Sucampo Pharmaceuticals named Glenn Noronha, Ph.D., vp, research and development. Before joining Sucampo, he was CSO at JW Theriac. Prior to that, Dr. Noronha held leadership roles at Alcon Laboratories, now part of Novartis. He also filled positions at TargeGen, now acquired by Sanofi-Aventis.

 

Christine E. Garnett is now principal scientist at Certara...Illumina added Paul Bianchi as svp of human resources...Kane Biotech appointed Gord Froehlich to its board of directors...Circassia hired Stewart Sharpe as vp of commercial operations...Northwest Biotherapeutics added Günter Rosskamp, Ph.D., as CEO of its German subsidiary...Vertex named Yuchun Lee to its board of directors.